Serum Institute of India CEO Adar Poonawalla has offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the firm for Rs 118 crore, through an open market transaction. The shares were picked by Serum Institute of India (SII).
Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.